ORKA Latest News, Press Relases and Analysis

All

Press Releases

22 days ago - By: Benzinga - Mentions: VCIG SPY AEHR GOOG ...

Stock Market Today: Nasdaq, S&P 500 Futures Rise As Government Enters 2nd Week Of Shutdown—Plug, Lithium Americas, UiPath In Focus

23 days ago - By: Benzinga - Mentions: AEHR STZ SKYT VCIG

Constellation Brands, Aehr Test Systems And 3 Stocks To Watch Heading Into Monday

a month ago - By: Stocktwits - Mentions: MLTX SLRN

MoonLake Stock Climbs After-Hours: Retail Traders Shrug Off Record Plunge, More Wall Street Downgrades

a month ago - By: Investor's Business Daily - Mentions: MLTX

MoonLake Crashes 89% On Mixed Results For Skin Disease Treatment

4 months ago - By: Oruka Therapeutics, Inc.

Oruka Therapeutics Announces Promotion of Laura Sandler to Chief Operating Officer

a month ago - By: Investor's Business Daily - Mentions: AAPL ABBV

Oruka Therapeutics, Up 20%, Is Trying To Take On AbbVie's Biggest Moneymaker

a month ago - By: Oruka Therapeutics, Inc.

Oruka Therapeutics Announces $180 Million Private Placement

a month ago - By: Oruka Therapeutics, Inc.

Oruka Therapeutics Announces $180 Million Private Placement

a month ago - By: Oruka Therapeutics, Inc.

Oruka Therapeutics Announces Positive Interim Phase 1 Results for ORKA-001

a month ago - By: Oruka Therapeutics, Inc.

Oruka Therapeutics Announces Positive Interim Phase 1 Results for ORKA-001

3 months ago - By: Oruka Therapeutics, Inc.

Oruka Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

3 months ago - By: Oruka Therapeutics, Inc.

Oruka Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

3 months ago - By: Oruka Therapeutics, Inc.

Oruka Therapeutics Announces IND Clearance for EVERLAST-A Phase 2a Trial of ORKA-001 in Psoriasis with Phase 1 Data to be Presented at EADV in September

3 months ago - By: Oruka Therapeutics, Inc.

Oruka Therapeutics Announces IND Clearance for EVERLAST-A Phase 2a Trial of ORKA-001 in Psoriasis with Phase 1 Data to be Presented at EADV in September

4 months ago - By: Oruka Therapeutics, Inc.

Oruka Therapeutics Announces Promotion of Laura Sandler to Chief Operating Officer

5 months ago - By: Yahoo Finance - Mentions: MLTX LUV

Fertility financing 101: How to afford IVF

5 months ago - By: Yahoo Finance - Mentions: MLTX PTON AAPL

H.C. Wainwright Maintains Buy Rating on MoonLake Immunotherapeutics (MLXT), Keeps PT

5 months ago - By: Yahoo Finance - Mentions: MLTX RXRX AAPL

H.C. Wainwright Maintains Buy Rating on Oruka (ORKA) After the Early Start of OKRA-002 Trial

5 months ago - By: Yahoo Finance - Mentions: HAS MGM V AAPL

Airwallex Raises $300M As It Expands In U.S. And Latin America, Now Valued At $6.2B With Clients Like Shein And Xero

5 months ago - By: Oruka Therapeutics, Inc.

Oruka Therapeutics to Present at the Jefferies Global Healthcare Conference

5 months ago - By: Oruka Therapeutics, Inc.

Oruka Therapeutics to Present at the Jefferies Global Healthcare Conference

5 months ago - By: Oruka Therapeutics, Inc.

Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of ORKA-002, its Novel Half-life Extended Anti-IL-17A/F Antibody

5 months ago - By: Oruka Therapeutics, Inc.

Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of ORKA-002, its Novel Half-life Extended Anti-IL-17A/F Antibody

6 months ago - By: Oruka Therapeutics, Inc.

Oruka Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

6 months ago - By: Oruka Therapeutics, Inc.